| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/28/2010 | EP2209471A2 Lipoxin a4 protection for cornea endothelial cells |
| 07/28/2010 | EP2209470A1 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field |
| 07/28/2010 | EP2209371A1 Compositions and methods for treatment of diabetic retinopathy |
| 07/28/2010 | EP1827406B1 Anti-radical agents |
| 07/28/2010 | EP1814848B1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 07/28/2010 | CN1794988B Composition for treating vascular hyperpermeable disease |
| 07/28/2010 | CN101790527A benzothiophene inhibitors of rho kinase |
| 07/28/2010 | CN101787063A Anti-infective medicament and preparation and application thereof |
| 07/28/2010 | CN101786993A 1, 2, 3-triazole compound and application thereof in preparing indoleamine 2, 3-dioxygenase inhibitor |
| 07/28/2010 | CN101785854A Lutein multivitamin nutrition health care medicine composite and preparation method and applications thereof |
| 07/28/2010 | CN101785790A External use traditional Chinese medicine for tympanitis treatment |
| 07/28/2010 | CN101785788A Traditional Chinese medicine for cataract treatment |
| 07/28/2010 | CN101785756A Celtezole sodium suspension preparation and novel application thereof |
| 07/28/2010 | CN101185650B Penciclovir ophthalmic temperature sensitivity in situ gel preparation and preparation method thereof |
| 07/28/2010 | CN101081091B Vision-improving and intelligent-improving beverage |
| 07/27/2010 | US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 07/27/2010 | US7763621 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 07/27/2010 | CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors |
| 07/27/2010 | CA2457034C Ophthalmic composition comprising an ascomycin |
| 07/27/2010 | CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2384717C Topical treatment for prevention of ocular infections |
| 07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
| 07/22/2010 | WO2010082326A1 Ozone/oxyglutathione ocular perfusion liquid and washing liquid and method of producing the same |
| 07/22/2010 | WO2010081823A1 Pirenzepine as otoprotective agent |
| 07/22/2010 | WO2010062523A3 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 07/22/2010 | WO2010048332A3 Compounds for treating ophthalmic diseases and disorders |
| 07/22/2010 | WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 07/22/2010 | WO2009137339A3 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 07/22/2010 | US20100184856 Novel Compounds and Uses Thereof for Treating Inflammation and Modulating Immune Responses |
| 07/22/2010 | US20100184838 Compositions and methods for retinal transduction and photoreceptor specific transgene expression |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184769 Pde inhibitors for the treatment of hearing impairment |
| 07/22/2010 | US20100184755 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184695 Vascular endothelial cell-binding peptide |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin |
| 07/22/2010 | US20100184676 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184664 Ophthalmic compositions useful for improving visual acuity |
| 07/22/2010 | US20100184659 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 07/22/2010 | US20100183696 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists |
| 07/22/2010 | US20100183629 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 07/22/2010 | US20100183587 Therapeutic Compositions for Treatment of Corneal Disorders |
| 07/22/2010 | US20100183572 Cell capable of expressing lacritin at high level |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/21/2010 | EP2207767A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 07/21/2010 | EP2207598A1 Methods and compositions for treating dry eye |
| 07/21/2010 | EP2207530A2 Sustained delivery of compstatin analogs from gels |
| 07/21/2010 | EP1613621B1 Prostaglandin analogs as ep4 receptor agonists |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
| 07/21/2010 | CN101784285A Composition for ophthalmic disease associated with hypoxia or ischemia |
| 07/21/2010 | CN101784275A compositions and methods for modulating endophthalmitis using fluoroquinolones |
| 07/21/2010 | CN101781347A Polymorphic substances of decitabine and medical compositions |
| 07/21/2010 | CN101780228A Traditional Chinese medicine composition for treating tinnitus and preparation method thereof |
| 07/21/2010 | CN101780105A Eye drop of deproteinized calf blood extractive |
| 07/21/2010 | CN101780076A Application of pharmaceutical composition containing tacrolimus in treating dry eye syndrome |
| 07/21/2010 | CN101780034A Cefathiamidine suspension and novel application thereof |
| 07/21/2010 | CN101129385B Ophthalmic composition containing gatifloxacin and lotepredenol etabonate and method of preparing the same |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759333 pentaazacycle manganese complexes, as mimetics for oxidoreductase enzymes,used for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects |
| 07/20/2010 | US7759322 Method of treating dry eye disease with purinergic receptor agonists |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7758883 first layer has polyvinyl alcohol, polyvinyl acetate, and polyvinyl pyrrolidone; aqueous layer over the first layer;and a layer of a phospholipid (e.g., lecithin) over the aqueous layer; for treating dry eye syndrome |
| 07/20/2010 | CA2455680C Ophthalmic depot formulations for periocular or subconjunctival administration |
| 07/20/2010 | CA2377290C Utilization of a highly fluorinated oligomeric alkane in ophthalmology |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/15/2010 | WO2010081091A2 Therapeutic compositions for treatment of corneal disorders |
| 07/15/2010 | WO2010080563A2 Method for treating macular degeneration |
| 07/15/2010 | WO2010079910A2 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079421A1 Use of deuterium oxide for treating viral diseases of the eye |
| 07/15/2010 | WO2010017626A8 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 07/15/2010 | US20100179220 Method for the treatment of tinnitus |
| 07/15/2010 | US20100179218 Oculoselective drugs and prodrugs |
| 07/15/2010 | US20100179203 Novel pyrazole derivatives useful as potassium channel modulators |
| 07/15/2010 | US20100179177 Heterocyclic compounds and their uses |
| 07/15/2010 | US20100179175 Use of pkc inhibitors in ocular diseases |
| 07/15/2010 | US20100179140 Indenoisoquinolinone analogs and methods of use thereof |
| 07/15/2010 | US20100179117 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 07/15/2010 | US20100179109 Renin inhibitors |
| 07/15/2010 | US20100178316 Extended release of bioactive molecules from silicone hydrogels |
| 07/15/2010 | US20100178315 Polymeric systems for controlled drug therapy |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/15/2010 | CA2749537A1 Therapeutic compositions for treatment of corneal disorders |
| 07/15/2010 | CA2747478A1 Method for treating macular degeneration |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2205234A2 Methods and compounds for treating retinol-related diseases |
| 07/14/2010 | EP2205071A1 Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and trkb agonists |
| 07/14/2010 | EP1486494B1 N-substituted benzothiophenesulfonamide derivative |
| 07/14/2010 | EP1261357B1 Isolation and transplantation of retinal stem cells |